Effects of high dose of zoledronic acid on superficial vascular network of membranous bone sites: an intravital study on rat calvarium
- PMID: 20020279
- DOI: 10.1007/s00198-009-1146-0
Effects of high dose of zoledronic acid on superficial vascular network of membranous bone sites: an intravital study on rat calvarium
Abstract
We evaluated the impact of high dose of zoledronic acid on the superficial vascular network parameters of a membranous bone site. During a 5-day follow-up, significant reduction of the vascular density is observed only in the treated group.
Introduction: The superficial vascularization is of great importance in membranous bone-healing process. A new rat calvarium intravital model was developed to study the short-term effect of a single high dose of zoledronic acid infusion on the superficial vascularization.
Methods: Optical bone chambers were implanted in the bone tissue surface of Sprague-Dawley rats' calvarium. Nine rats were injected i.v. with 400 µg/kg of zoledronic acid (Z group), and nine rats were injected with vehicle (PSS group). A 5-day follow-up of the vascular network was made by the use of pictures analysis method.
Results: The vascular density significantly decreases only in Z group but there was no significant difference between groups at individual time points. The total length of the vascular network decreases significantly in Z group only (p=0.003) with a significant higher decrease at D3 (p=0.04) and D5 (p=0.02) compared with control. The vascular density related to the smaller vessels (width, 5-10 µm) decreases significantly between T0 and D5 in Z group only (p=0.002).
Conclusions: With the help of an original intravital animal model a significant modifications on the total length of the vascular network and the vascular density of small vessels are highlighted on a membranous bone site.
Similar articles
-
No anti-angiogenic effect of clinical dosing regimens of a single zoledronic acid injection in an experimental bone healing site.Bone. 2010 Mar;46(3):643-8. doi: 10.1016/j.bone.2009.10.034. Epub 2009 Nov 4. Bone. 2010. PMID: 19895916
-
Zoledronic acid suppresses callus remodeling but enhances callus strength in an osteoporotic rat model of fracture healing.Bone. 2015 Dec;81:702-711. doi: 10.1016/j.bone.2015.09.018. Epub 2015 Oct 3. Bone. 2015. PMID: 26434668
-
Effect of Zoledronic Acid Application on Different Graft Materials in Calvarial Bone Defect Models. An Experimental Analysis.Anal Quant Cytopathol Histpathol. 2016 Apr;38(2):117-25. Anal Quant Cytopathol Histpathol. 2016. PMID: 27386633
-
Preclinical studies with zoledronic acid and other bisphosphonates: impact on the bone microenvironment.Semin Oncol. 2001 Apr;28(2 Suppl 6):35-44. doi: 10.1016/s0093-7754(01)90263-5. Semin Oncol. 2001. PMID: 11346863 Review.
-
[Preclinical and clinical profile of zoledronic acid (Zometa) for hypercalcemia of malignancy].Nihon Yakurigaku Zasshi. 2005 Nov;126(5):353-7. doi: 10.1254/fpj.126.353. Nihon Yakurigaku Zasshi. 2005. PMID: 16394581 Review. Japanese. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources